Serum Sample Clauses

Serum. High resolution protein electrophoresis patterns are primarily interpreted by comparing the relative intensities of the bands obtained on unknown specimens with those obtained on known normal individuals. One of the most common abnormal serum protein patterns is that observed in the non-specific inflammatory response which is characterized by an increase in α1-antitrypsin and haptoglobin with decreased prealbumin, albumin and transferrin. While it is not useful in establishing a general diagnosis, it is useful in monitoring a patient’s response to therapy. Other examples of clinically important variations are: - elevation of the transferrin band, suggesting a low level of iron - presence of monoclonal proteins, suggesting abnormalities of the immune system - low haptoglobin, suggesting elevated RBC turnover or in-vitro hemolysis - CRP presence, indicating an acute inflammatory response - low prealbumin, albumin and transferrin with diffuse hypergammaglobulinemia, suggesting chronic inflammation, infection or antigenic stimulation - low C3 on fresh samples, suggesting complement consumption.
AutoNDA by SimpleDocs
Serum. The patient serum samples are diluted 1:3 (1 part serum with 2 parts 0.85% saline) for serum protein lanes and diluted 1:5 (1 part serum with 4 parts 0.85% saline) for immunofix lanes. NOTE: Due to desired sensitivity variations, serum samples may also be diluted as follows: IgG = 1:5 to 1:10 IgA = undiluted to 1:5 IgM = undiluted to 1:5 κ = undiluted to 1:10 λ = undiluted to 1:5 The more concentrated samples are more likely to prozone while the more diluted samples may not exhibit desired sensitivity.
Serum. The patient serum samples are diluted 1:3 (1 part serum with 2 parts 0.85% saline) for serum protein lanes and diluted 1:5 (1 part serum with 4 parts 0.85% saline) for immunofix lanes.
Serum 

Related to Serum

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Insulin Insulin will be treated as a prescription drug subject to a separate copay for each type prescribed.

  • Probes Network hosts used to perform (DNS, EPP, etc.) tests (see below) that are located at various global locations.

  • Screening 3.13.1 Refuse containers located outside the building shall be fully screened from adjacent properties and from streets by means of opaque fencing or masonry walls with suitable landscaping.

  • Vaccination and Inoculation (a) The Employer agrees to take all reasonable precautions, including in-service seminars, to limit the spread of infectious diseases among employees.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Preceptor A per diem Registered Nurse 2 may serve as a preceptor after successfully completing a preceptor workshop or equivalent documented training and agreeing to and being appointed to be specifically responsible for planning, organizing, and evaluating the new skill development of one or more RNs as appropriate enrolled in a defined orientation program, the parameters of which have been set forth in writing by the Employer. This includes teaching, clinical supervision, role modeling, feedback, evaluation (verbal and written) and follow up of the new or transferring employee. The per diem RN 2 preceptor is eligible to receive preceptor premium pay when actually engaged in preceptor role responsibilities with/on behalf of the orienting RN. A per diem RN 2 substituting for the original preceptor during a period of absence and who has been designated to carry out the preceptor's complete responsibility (including following and/or adjusting the plan to meet learning needs and providing oral and written evaluation input) will receive preceptor pay. A preceptor may be assigned to a student when it is determined by the Employer that the employee has completed the required preceptor training or has agreed to and been appointed a preceptor. The employee is specifically responsible for planning, organizing, and evaluating the new skill development of the student as appropriately enrolled in a defined program, the parameters of which have been set forth in writing by the Employer. This includes teaching, clinical supervision, role modeling, feedback, evaluation (verbal and written) and follow up of the student.

  • RE-WEIGHING PRODUCT Deliveries are subject to re- weighing at the point of destination by the Authorized User. If shrinkage occurs which exceeds that normally allowable in the trade, the Authorized User shall have the option to require delivery of the difference in quantity or to reduce the payment accordingly. Such option shall be exercised in writing by the Authorized User.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

Time is Money Join Law Insider Premium to draft better contracts faster.